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ABSTRACT  Giant axonal neuropathy (GAN) results from autosomal recessive mutations (gan-) 
that affect  cytoskeletal  organization;  specifically,  intermediate  filaments  (IFs) are found  col- 
lapsed into massive  bundles in a variety of different cell types. We studied the gan- fibroblast 
lines  WG321  and  WG139  derived  from  different  GAN  patients.  Although  previous  studies 
implied  that the gan-  IF  phenotype was constitutive,  we find  that  it  is conditional.  That  is, 
when cells were grown under the permissive condition of medium  containing over 2% fetal 
calf serum,  most cells had  normal  IF organization.  IF bundles formed  when gan- cells were 
transferred  to  the  nonpermissive  condition  of  low  (0.1%)  serum.  Microtubule  organization 
appeared  normal  in the  presence or absence of serum. The effect  of serum  starvation was 
largely  blocked  or  reversed  by  the  addition  of  BSA  to  the  culture  media.  We  found  no 
evidence that the gan- phenotype depends upon progress through the cell cycle. We discuss 
the possible role of serum effects  in the etiology of GAN and speculate as to the molecular 
nature of the gan- defect. 
Giant axonal neuropathy (GAN) ~  is a rare, slowly progressive 
central-peripheral  distal  axonopathy  (1,  40,  41);  symptoms 
first appear in children between the ages of 3 and  5 yr. The 
identification  of related  siblings  with  GAN  (21),  parental 
consanguinity of some GAN patients (11,  18, 41), studies of 
a genetic disease with similar symptoms in inbred dogs (7, 8), 
and  the  persistence  of aberrant  intermediate  filament  (IF) 
phenotype in cultured cells derived from GAN patients (37- 
39;  see below)  indicate  that  GAN  is a  genetic disease,  and 
results from an autosomal recessive mutation(s) (gan-).  For 
the  student  of cell  biology,  GAN  is  of particular  interest 
because it is one  of only a  handful  of mutations  known  to 
affect cytoskeletal organization  and  function.  Most of these 
mutations  affect either actin  or tubulin  genes;  they include 
mutations  in  Saccharomyces cerevisiae (35,  47),  Schizosac- 
charomyces pombe  (50),  AspergiUus (34,  46),  Drosophilia 
melanogaster (23, 24), Caenorhabditis elegans (15), and cul- 
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Rd,  tetramethylrhodamine-conjugated,  affinity-purified  goat  anti- 
mouse immunoglobulin antisera;  anti-MTOC, monoclonal antimi- 
crotubule-organizing  center;  GAN, giant axonal neuropathy; gan-, 
autosomal  recessive  mutations;  IF,  intermediate  filament;  MEM, 
minimal essential medium; MTOC, microtubule-organizing center. 
tured Chinese hamster ovary cells (4-6, 22). gan- is the only 
mutation known to affect IF organization specifically. 
Diagnosis is of GAN is based upon the presence of large, 
focal  accumulations  of neuronal  IFs that  cause  regions  of 
nerve  axons  to  "balloon."  These  IF  bundles  first  appear 
distally  in  neurons  that  project  into  the  periphery;  as  the 
disease  progresses,  central  neurons  that do  not  project  into 
the periphery can also become affected (25,  40). Ultrastruc- 
rural examination ofgan- tissues reveals abnormal IF bundles 
not only in neurons, which express the neuron-specific triplet 
of IF subunit proteins; but also in astrocytes, Schwann cells, 
endothelial cells, and skin fibroblasts (40, 41), which express 
their own distinctive IF subunit proteins (see reference 36 for 
review). In addition, all but two of the GAN patients reported 
(20,  40) have had  unusually  kinky hair (1,  41),  which  is of 
interest because hair is composed of epithelial IF (10, 51). 
To characterize the molecular defect underlying GAN, we 
have studied two independently  isolated, gan- human  fibro- 
blast cell  lines.  In contrast  to  previous  reports  (37-39),  we 
find that gan- mutations have a conditional, not a constitutive 
IF phenotype, and that this phenotype appears to be mediated 
by serum factors. 
MATERIALS  AND  METHODS 
Cell Culture:  we studied the gan- skin fibroblast lines, WO321  and 
WGI39, and the normal (GAN +) human foreskin fibroblast line, MCH7, which 
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Laboratory for Biochemical Geneties/McGill University-Montreal Children's 
Hospital  Research  Institute. Cells were grown  in  minimal essential media, 
Eagle's modification (MEM),  supplemented with  10%  heat-inactivated fetal 
calf serum,  10  mM  HEPES,  and  antibiotics, either penicillin/streptomycin 
or  gentamycin  (10%  MEM).  Alternatively,  10%  Nu-Serum  (Collaborative 
Research  Inc.,  Waltham,  MA),  6-20  mg/ml  BSA, Cohn  fraction  V  (Sigma 
Chemical Co., St.  Louis, Mo.--Iot 113F-0273, described as 96-99% albumin), 
or  10 mg/ml ovalbumin (Sigma Chemical Co.,  grade V--lot  331:-8110,  de- 
scribed as electrophoretically pure and ~99%  pure) were substituted for fetal 
calf serum. The purity of the BSA used in our experiments was over 98% as 
determined by PAGE (30). 
Cells were grown at 37°C in a humidified, 5% CO2 incubator, and were used 
at  low passage number  (<12) and low total cell doublings (estimated to be 
<40). Cells were passaged using trypsin and EDTA. For immunofluorescence 
microscopy, cells were grown on glass coverslips. Cultures were fed every 3-4 
d  with fresh  10%  MEM;  experiments were performed  8-14  d  after plating. 
When media conditions were changed, cultures were washed three times with 
warmed  MEM  containing HEPES,  and  then  fed  with  medium  containing 
appropriate additives. Cells could be maintained in 0-0.1% serum for over 5 d 
without apparent effects on viability. Occasionally we observed wholesale cell 
death  in  some  colonies in  response to  repeated cycles of serum  starvation; 
although some colonies died, the majority appeared normal. In addition, we 
observed what appeared to be an increase in the variation of the response of 
gun- cells to serum conditions with increasing  age in culture; the results reported 
here  are  based  solely nonsenescent  cells,  passaged less than  12  times,  and 
subjected to only a single cycle of serum starvation. 
Monoclonal Antibodies and Immunofluorescence  Micros- 
copy:  IFs were visualized using the monoclonal anti-intermediate filament 
antibody anti-IF(1.4E9). Anti-IF(1.4E9), an IgM, was generated using cytoskel- 
etal extracts as immunogen and reacts with human, chick, and mouse vimentin 
and Potoroo tridactylus-derived PtK~  kidney epithelial keratins as determined 
by  Western  immunoblot  analysis  and  immunofluorescence  microscopy 
(Klymkowsky, M. W., work in progress). Microtubule organization was visu- 
alized by using the monoclonal antitubulin antibody 4Al (antitubulin) gener- 
ated  by  Dr.  M.  Fuller  (University  of Colorado)  and  a  monoclonal  anti- 
microtubule-organizing center  antibody C29  (anti-MTOC)  generated by  T. 
Mitchison (University of California, San Francisco). 
lmmunofluorescence microscopy was carried out as described previously 
(27,  28).  For  double  immunolabeling with anti-MTOC  and  anti-IF(l.4E9), 
anti-MTOC  was  applied  first,  labeled with  fluorescein-conjugated, affinity- 
purified goat anti-mouse immunoglobulin antisera (anti-Mlg-F1)(l:100), fol- 
lowed by anli-lF(l.4E9) and tetramethylrhodamine-conjugated, affinity-puri- 
fied goal  anti-mouse immunoglobulin antisera (anti-MIg-Rd)(l:100). Under 
these conditions, the anti-IF(l.4E9) and anti-Mlg-Rd antibodies labeled the 
anti-MTOC/anti-Mlg-Fl complex; the small size of the microtubule-organizing 
center (MTOC) led to image confusion in only a small and readily identifiable 
region of the cell. 
Antibody incubations were carried out for 20 min at  room temperature. 
Conjugates were purchased from Cappel Laboratories (Cochranville, PA); there 
was no noticeable, nonspecific labeling by any of the conjugates. 
Coomassie Labeling of Cells:  To examine the overall organization 
of IFs in cell colonies, we employed a slightly  modified version of the Coomassie 
Brilliant Blue-staining procedure developed by Pena (37).  Cultures were ex- 
tracted with 60 mM  PIPES, 25 mM  HEPES,  l0 mM  EGTA, 2  mM  MgCl2, 
0.02%  NAN3, 0.15%  Triton  X-100 (42), and then fixed for  10 rain at room 
temperature with 4% formaldehyde in PBS. After fixation, cultures were stained 
with  0.2%  Coomassie  Brilliant Blue  R250  in  7%  acetic  acid  and  46.5% 
methanol for 5 rain, destained with 5% methanol/5% acetic acid, and then air- 
dried. Coomassie-stained cultures were viewed under bright-field optics; cells 
with IF bundles could be identified unambiguously (Fig. 1, C and F ). Typically, 
between  40  and  50%  of the  cells (200-1,200  cells) within  each  of  10-14 
independent  colonies  were  examined  for  each  experimental  condition.  In 
certain cases (see Fig. 3 B), all of the cells in the colonies examined were scored. 
Colonies were chosen for examination at random and once chosen no colony 
was discarded. 
Autoradiography:  Cells undergoing active DNA  synthesis were la- 
beled by incubating cultures for 24 h  in  l  t~Ci [3H]thymidine (New England 
Nuclear, Boston,  MA) per milliliter of media. After Coomassie staining and 
air-drying (see above), culture dishes were coated with Kodak NTB-2 emulsion 
diluted l:l with water. The emulsion was dried at room temperature, exposed 
at  0*C  for  7-10  d,  and  developed  with  Dl9,  as  described  by  Stein  and 
Yanishevsky (48).  Nuclei with >50 autoradiographic grains over them were 
scored as labeled: this value was chosen to provide an unambiguous index of 
labeling; lower numbers of automdiographic grains were often obscured by the 
Coomassie Brilliant Blue staining of nuclei (see Fig.  1).  Most nuclei (>80%) 
were  very heavily labeled,  i.e.,  >500  grains.  In  this series of experiments, 
background labeling was <l grain per 100/zm  2. 
RESULTS 
Pena first described the presence of large bundles of vimen- 
tin-type IFs in  the  cultured  gan-  fibroblast  lines  WG321, 
WG129,  and  WG791  (37,  38).  These reports claimed that 
>90%  of the  cells  contained  IF  bundles;  no  mention  of 
variations in  the  percentage of cells containing  IF bundles 
was made. We were therefore surprised to find in our initial 
immunofluorescence studies that both WG 139 and WG321 
cells showed either a normal or a "collapsed" IF phenotype 
(Fig.  1, A-C), and  that the  percentage of cells containing 
detectable IF bundles was often <20% (Fig.  1 C). As reported 
by Pena et al. (39), microtubule organization appeared normal 
in all cells (Fig. 2). 
We initially assumed that the variability in IF organization 
in gan- cells was due to difference between clones. We have 
observed apparent  clonal  variations in  the  organization  of 
HeLa  (31)  and  LCC-PKI  cell  IFs  (Klymkowsky,  M.  W., 
unpublished observations). To test the possibility that clonal 
variation was the cause of the discrepancy between our results 
and those of Pena,  200-400  WG321  or WG139 cells  were 
plated into 60-mm diam tissue culture  petri dishes; exami- 
nation of these cultures within 24 h of plating confirmed that 
>80% of the cells were single,  isolated cells.  Within  8-12 d 
colonies had grown up from these cells, and the presence of 
IF bundles was assayed using the  Coomassie Blue-staining 
method; every colony contained some cells with and some 
without IF bundles (Figs.  1 C and 3A). The percentage of cells 
with  IF  bundles  varied  among  colonies  within  the  same 
culture (Fig. 3A). 
Reasoning that variations in IF organization between clon- 
ally derived gan- cells could be due to their relative positions 
within the cell cycle, cells growing in colonies were synchro- 
nized by serum starvation (0-0.1% fetal calf serum). Within 
24 h, the majority of serum-starved WG139 and WG321 cells 
contained  IF bundles  (Figs.  1F and  3A).  Examination  of 
serum starvation-induced IF reorganization by immunofluo- 
rescence  microscopy revealed that  the  initial  phases of IF 
FIGURE  I  IF organization in WG321  cells grown continuously in 10% MEM (A-C) or 24 h after transfer to 0.1% fetal calf serum 
containing-medium (D-F) was examined by indirect immunofluorescence microscopy (A and D, phase optics; B and E, rhodamine 
optics) or Coomassie Brilliant Blue staining (C and F). For immunofluorescence microscopy, cells were labeled with anti-MTOC, 
anti-MIg-FI,  anti-IF(1.4E9),  and  anti-MIg-Rd.  IF  organization appeared  normal  in  most  cells  grown  in  10%  MEM,  although  IF 
bundles were found in some (A and B). When maintained in 0.1% serum, most cells contained IF bundles (D and E). Arrows in B 
and E mark the positions of MTOC as determined by examination of cells under fluorescein optics (not shown). The percentage 
of cells with normal and collapsed IF can better be judged by Coomassie staining: few cells contained IF bundles in 10% MEM 
(arrows, C), whereas in 0.1% serum (F) the great majority of cells contained IF bundles. One or two IF bundles were found  in 
most  cells,  and  these  assumed  a  number  of  different  shapes,  ranging from  compact  bundles  (arrows)  to  perinudear  rings 
(arrowheads). Bars,  10 #m (A);  100 ~.m (C). x  410 (A, B, D, and E); x  190 (C and F). 
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FIGURE  2  The organization of microtubules in WG321  cells grown 
in the presence (A,  phase optics; B, fluorescein optics) or absence 
(C,  phase  optics;  D,  fluorescein  optics)  of  fetal  calf  serum  was 
revealed by immunoiluorescence microscopy using antitubulin and 
anti-Mlg-FI. Microtubule organization appeared normal in the pres- 
ence or absence of serum. IF bundles are visible under phase optics 
(arrows in C) in cells grown in the absence of serum; the apparent 
positions of MTOC  can be discerned from the pattern of microtu- 
bule labeling (arrowheads in D). Bar,  10 #m. x  450. 
collapse were evident within 4  h  after the removal of serum 
(not shown), and essentially complete in most cells within 24 
h (Figs.  1, D-Fand 3A). Parallel studies ofcolchicine-induced 
IF bundle formation in normal GAN  ÷ MCH7 cells indicated 
that the time course of IF collapse in gan- cells is similar to 
that observed in  response  to  microtubule  depolymerization 
(not shown). In contrast to drug-induced IF collapse, micro- 
tubules remained intact within serum-starved, gan- cells (Fig. 
2, C and D). Because both WG321 and WG 139 cells showed 
similar conditional IF phenotypes (Fig. 3 A), we chose to carry 
out most of our experiments using the WG321 cell line. 
We have  never observed a  serum  starvation-induced col- 
lapse  of IF in  normal  MCH7  (GAN  ÷) fibroblasts;  their  IF 
networks appeared normal by both immunofluorescence mi- 
croscopy and Coomassie staining in the presence or absence 
of serum (not shown). Only rarely, i.e.,  in <0.1% of the cells, 
were small IF bundles found in MCH7 cells (not shown). 
The collapse of IF was readily reversed by returning serum- 
starved cells to fetal calf serum-containing media (Fig.  3 B). 
Normal  IF  organization  as  also  found when  Nu-Serum,  a 
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FIGURE  3  (A) The  percentage of  IF  bundles found  in colonies of 
WG139  cells  (left) and  WG321  cells  (right) was  low  in  cultures 
grown  in  10%  fetal  calf  serum-containing  media  (CONTROL). 
Within  24  h  (24H)  after transfer of  sister cultures 0.1%  fetal  calf 
serum-containing media, the  percentage of cells with  IF  bundles 
had increased considerably; after 72  h (72H) most but not all cells 
contained  IF  bundles. Three separate experiments are plotted for 
the 72-h serum-starvation response of WG321  cells. (B) To titer the 
effect of fetal calf serum on IF phenotype, WG321  cells were grown 
as colonies for 8  d  in  10% MEM  and then  transferred  into  media 
containing varying amounts of fetal calf serum. After 24 h, 1 /zCqml 
[3H]thymidine was added to each culture. The cells were examined 
after 24 h in [3H]thymidine by Coomassie Brilliant Blue staining and 
autoradiography.  10-12  colonies  on  each  plate  were  chosen  at 
random; all cells were counted for the presence of IF bundles and 
nuclear  autoradiographic  labeling.  The  percentage  of  fetal  calf 
serum  (PERCENT FCS) and  the  percentage of  cells  labeled  with 
[3H]thymidine (MITOTIC  INDEX)  are noted on the bottom of the 
graph. The percentage of all cells containing IF  bundles is shown 
with circles; triangles indicate the  percentage of autoradiographi- 
cally labeled cells with IF bundles. 
low-protein serum  substitute,  was used  instead  of fetal  calf 
serum (Fig. 4, a  and g). Recovery of a  normal IF phenotype 
was complete in most cells after 24 h  in fetal calf serum or 
Nu-Serum (Figs. 3B and 4g). Titration of the fetal calf serum 
effect on IF organization revealed a  threshold  level of ~ 1% 
serum (Fig. 3 B). There was a clear increase in the variability 
of IF phenotype between  colonies at  serum  concentrations 
between 0.2%  and 0.5%  (Fig.  3B), suggesting that the gan- 
IF phenotype of different WG321  cell  clones had  different 
serum-threshold levels. 
Immunofluorescence labeling of WG321 cells with antitu- 
bulin antibody revealed normal,  intact microtubule systems in both the presence (Fig. 2, A and B) and absence (Fig. 2, C 
and D) of serum. IF bundles can often be identified under 
phase-contrast optics (Fig.  2 C--arrows), there seemed to be 
little  interaction  between  the  microtubule  system  and  IF 
bundles in most cases (Fig. 2, Cand D). The MTOC remained 
near the nucleus (Figs.  1 and 2D) in most cells (although see 
Fig.  1B), and sometimes appeared to associate with the pe- 
riphery of the IF bundle (Fig.  1, B and E). Whether associa- 
tions between IF bundles and MTOC were fortuitous or reflect 
significant interaction between the two remains to be deter- 
mined. 
Serum-induced  recovery  of normal  IF  organization  oc- 
curred when DNA synthesis was inhibited by either  10 mM 
thymidine or 2  mM  hydroxyurea (Fig.  4,  h  and  i),  which 
indicates that progress through the S phase of the cell cycle 
was  not  required  for  normal  IF  phenotype  in  gan-  cells. 
Autoradiographic analysis ofgan- cells recovering from serum 
starvation-induced IF collapse revealed no obvious correla- 
tion between DNA synthesis (mitotic index) and recovery of 
normal IF organization (Fig. 3 B). We have not attempted to 
determine  whether  protein  synthesis  was  required  for the 
reorganization  of  IF  because  protein  synthesis  inhibitors 
themselves have been reported to affect IF organization (45). 
The absence of a correlation between the formation of IF 
bundles and progress through the cell cycle led us to suspect 
the involvement of serum factors in producing the gan- IF 
phenotype. BSA at concentrations of  6 or 20 mg/ml prevented 
the  formation  of IF bundles  in  serum-deprived cells,  and 
reversed the serum starvation-induced IF collapse (Fig. 4, b, 
c, e, and f). Ovalbumin added at 10 mg/ml to MEM did not 
prevent IF collapse (not shown), indicating that the effect of 
BSA  was not due  simply to the  presence of protein in  the 
media. The BSA used in these experiments was judged >98% 
pure (see Materials and Methods). Because at least 1% whole 
serum was required to produce the same IF phenotype, we 
consider it unlikely that the  BSA effect was due  to  minor 
100 
80 
ul, 70 
o 
z 
8C  z 
•  4t 
-J  a¢ 
W 
~2 
WG321 
FORMATION 
4- 
t 
2_ 
RECOVERY 
| 
g  h  i  a  b  e  d  e  i 
FIGURE  4  WG321  cells were grown as colonies in  10% MEM for 
10 d  and then transferred to either 10% Nu-Serum (a), 20 mg/ml 
BSA (b), or 6 mg/ml BSA (c) containing serum-free MEM and assayed 
for the presence of IF bundles 24 h later by Coomassie staining. In 
a second experiment, cells in sister cultures  were transferred first 
to 0.1% fetal calf serum-containing  media for  48  h  (d) and  then 
returned to media containing 6  mg/ml BSA (e),  20 mg/ml  BSA (f), 
10% Nu-Serum (g),  10% MEM containing 10 mM thymidine (h), or 
10%  MEM  containing  2  mM  hydroxyurea  (i).  After  24  h  these 
cultures were examined by Coomassie staining. The percentage of 
cells containing IF bundles is plotted with the mean and standard 
deviation. 
serum contaminants present in the BSA preparation. How- 
ever, the effect of  BSA on gan- IF phenotype was less complete 
than that of either fetal calf serum or Nu-Serum; i.e., a greater 
percentage of cells contained IF bundles in the presence of 
BSA than in the presence of either fetal calf serum or Nu- 
Serum (Fig. 4). There may therefore be other factors present 
in serum that also contribute to the control IF phenotype in 
gan- cells. 
DISCUSSION 
The gan- mutations affect neuronal, glial, fibroblastic, and in 
some cases epithelial IF (40, 41). These IF are each composed 
of unique  proteins  coded  for  by  separate  genes  (36,  51). 
Biochemical comparison  of vimentin  from normal,  GAN  + 
and gan- fibroblasts reveals no obvious difference in either 
electrophoretic mobility or level of posttranslational modifi- 
cation (38;  Plummer, D. J., and M. W. Klymkowsky, work 
in progress) suggesting that the gan- defect does not affect IF 
proteins themselves, but rather a widely distributed compo- 
nent  involved in  the  control  of IF organization.  There  is 
mounting evidence that normal IF organization depends upon 
interactions with microtubules. Linking structures between IF 
and microtubules have been observed by electron microscopy 
in neuronal (14) and non-neuronal cells (42), and disruption 
of interphase microtubules by any of a number of means (2, 
3,  13,  16,  19, 44,  52) leads to the collapse of IF into bundles. 
However, in gan- cells IF collapse occurs even though micro- 
tubule  organization  appears unaltered  (Fig.  2).  In this  the 
phenotype of gan- is similar to that produced by heat shock 
(49) and intracellularly injected anti-IF antibodies (12,  26- 
28, 33). 
A number of compounds are known to induce neuronal IF 
disorganization when administered in vivo (reviewed in ref- 
erence 29).  Most of these agents cause the appearance of IF 
bundles in the proximal axon or within the perikaryon (29). 
In GAN, IF bundles form in the distal portion of axons that 
project into the periphery. The distal localization of IF bun- 
dles in GAN may be a  result of the involvement of serum 
factors  in  the  gan-  phenotype.  The  cell  bodies  of central 
neurons are shielded from direct interaction with serum fac- 
tors by the "blood-brain barrier." However, serum compo- 
nents are taken up by such neurons, and serum albumin has 
been shown to be the major retrogradely transported protein 
in  sciatic  nerve  (9,  32).  How  serum  factors  influence  IF 
phenotype of gan- cells is unclear. Morphological changes in 
response to serum starvation have been noted in neuroblas- 
toma cell lines; however, in these cases a,-, 0/4% and B-globulin, 
not serum albumin, were effective substitutes for whole serum 
(43).  In addition,  it remains to be explained why the  first 
symptoms of GAN  do  not  appear  until  relatively  late  in 
childhood. Perhaps IF bundles are formed earlier, but fall to 
produce symptoms until other events, such as myelination, 
occur. 
Although a  number of models for how gan- produces IF 
collapse are imaginable, we believe that the most likely is that 
gan- alters the interaction between IF and microtubules. That 
is,  when  cells are maintained  under  permissive conditions, 
there are enough links between microtubules and IF to main- 
tain normal IF organization in most cells. Under nonpermis- 
sive conditions, these links are broken and IF collapse. Assum- 
ing that gan- causes IF collapse by disrupting the links be- 
tween IF and microtubules, then a number of possible mech- 
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role of serum and, by implication, cellular metabolism in the 
gan-  phenotype,  we  favor  a  model  in  which  the  effective 
concentration  or binding  affinity  of linker  protein(s)  drops 
under nonpermissive conditions due to changes in either the 
relative rates of their synthesis, turnover, or posttranslational 
modification. 
One hint as to molecular basis of the restrictive (i.e., serum 
minus) gan- phenotype may come from the recent report that 
a number of different cell types synthesize a specific ensemble 
of proteins during Go arrest,  and that a  subset of these  "Go 
proteins" are also "heat shock" proteins (17). We are currently 
in the process of comparing heat shock and Go protein in 
GAN  + and gan- cells. 
The experimental disruption of IF organization by intra- 
cellular injection  of anti-IF  antibodies  has  no  recognizable 
affect on either cell morphology or behavior (12, 26, 28,  31, 
33).  Therefore,  we suspect that the symptoms of GAN and 
other neuropathies displaying altered IF organization are not 
due to the loss of normal IF organization per se, but result 
either  from  side  effects  due  to  the  presence  of massive  IF 
bundles  within  the  confines  of the  axon  or  to  metabolic 
alterations that only secondarily affect IF organization. 
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